Papers
Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients
BMJ 2002; 324 doi: https://doi.org/10.1136/bmj.324.7329.71 (Published 12 January 2002) Cite this as: BMJ 2002;324:71
Data supplement
BMJ 2002; 324:71 (12 Jan)
CORRECTION (10 Jan 2002)
The last sentence of this article has been corrected on the website to read: "For most healthy individuals, however, for whom the risk of a vascular event is likely to be substantially less than 1% a year, daily aspirin may well be inappropriate."
The online text therefore differs from the text that appears in the paper journal [which incorrectly ended "...may well be appropriate."]
A corrected pdf is available here
- Collaborators
- References for web tables A and B
- Figures
- Treatment Tables:
- Table A
- Table B
Related articles
- Editor's Choice Published: 12 January 2002; BMJ 324 doi:10.1136/bmj.324.7329.0/i
- This Week In The BMJ Published: 12 January 2002; BMJ 324 doi:10.1136/bmj.324.7329.0
- Editorial Published: 12 January 2002; BMJ 324 doi:10.1136/bmj.324.7329.59
- Education And Debate Published: 12 January 2002; BMJ 324 doi:10.1136/bmj.324.7329.103
- Education And Debate Published: 16 June 2005; BMJ 330 doi:10.1136/bmj.330.7505.1440
- Research Published: 01 September 2008; BMJ 337 doi:10.1136/bmj.a1198
- Practice Published: 26 April 2007; BMJ 334 doi:10.1136/bmj.39160.702188.AD
- PRIMARY CARE Published: 20 May 2005; BMJ doi:10.1136/bmj.38456.676806.8F
- Primary Care Published: 02 June 2005; BMJ 330 doi:10.1136/bmj.38456.676806.8F
- Education And Debate Published: 16 June 2005; BMJ 330 doi:10.1136/bmj.330.7505.1442
- Editorial Published: 16 October 2008; BMJ 337 doi:10.1136/bmj.a1806
- Research Published: 06 November 2009; BMJ 339 doi:10.1136/bmj.b4531
- Editorial Published: 06 November 2009; BMJ 339 doi:10.1136/bmj.b4596
- Editorial Published: 24 January 2008; BMJ 336 doi:10.1136/bmj.39405.635498.80
- Clinical Review Published: 20 October 2005; BMJ 331 doi:10.1136/bmj.331.7522.955
- Practice Published: 16 October 2008; BMJ 337 doi:10.1136/bmj.a1902
- Clinical Review Published: 14 June 2007; BMJ 334 doi:10.1136/bmj.39220.618646.AE
- Research Published: 11 May 2011; BMJ 342 doi:10.1136/bmj.d2690
- Research Published: 19 July 2011; BMJ 343 doi:10.1136/bmj.d4094
- Editorial Published: 19 July 2011; BMJ 343 doi:10.1136/bmj.d3942
- Clinical Review Published: 21 July 2011; BMJ 343 doi:10.1136/bmj.d4264
- Research Published: 12 June 2012; BMJ 344 doi:10.1136/bmj.e3750
- Research Published: 01 October 2013; BMJ 347 doi:10.1136/bmj.f5577
- Research Published: 26 November 2013; BMJ 347 doi:10.1136/bmj.f6954
- Letter Published: 17 May 2007; BMJ 334 doi:10.1136/bmj.39212.715590.3A
- Letter Published: 13 April 2002; BMJ 324 doi:10.1136/bmj.324.7342.917
- Letter Published: 19 January 2002; BMJ 324 doi:10.1136/bmj.324.7330.167
- Letter Published: 14 July 2005; BMJ 331 doi:10.1136/bmj.331.7509.160-b
- Research Published: 09 May 2018; BMJ 361 doi:10.1136/bmj.k1717
- Research Published: 18 December 2018; BMJ 363 doi:10.1136/bmj.k5108
- Student Published: 10 August 2010; BMJ 341 doi:10.1136/sbmj.c4103
See more
- Thrombectomy can be considered up to 24 hours after onset of stroke, says NICEBMJ November 23, 2018, 363 k4995; DOI: https://doi.org/10.1136/bmj.k4995
- Endovascular treatment for acute ischaemic stroke in routine clinical practice: prospective, observational cohort study (MR CLEAN Registry)BMJ March 09, 2018, 360 k949; DOI: https://doi.org/10.1136/bmj.k949
- Development and validation of outcome prediction models for aneurysmal subarachnoid haemorrhage: the SAHIT multinational cohort studyBMJ January 18, 2018, 360 j5745; DOI: https://doi.org/10.1136/bmj.j5745
- Lying flat after stroke achieves similar outcomes to sitting up, trial findsBMJ June 23, 2017, 357 j3051; DOI: https://doi.org/10.1136/bmj.j3051
- Long term aircraft noise is linked to incidence of high blood pressureBMJ June 14, 2017, 357 j2872; DOI: https://doi.org/10.1136/bmj.j2872
Cited by...
- Antithrombotics: From Aspirin to DOACs in Coronary Artery Disease and Atrial Fibrillation (Part 3/5)
- Preventive Management of Nonobstructive CAD After Coronary CT Angiography in the Emergency Department
- Low Level LASER Therapy Induces Therapeutic Angiogenesis in Diabetic Mice with Hindlimb Ischemia
- Secondary prevention therapies in acute coronary syndrome and relation to outcomes: observational study
- Clopidogrel plus aspirin versus aspirin alone for acute minor ischaemic stroke or high risk transient ischaemic attack: systematic review and meta-analysis
- Medical Therapy for Long-Term Prevention of Atherothrombosis Following an Acute Coronary Syndrome: JACC State-of-the-Art Review
- ACC/AHA Versus ESC Guidelines for Diagnosis and Management of Peripheral Artery Disease: JACC Guideline Comparison
- Humanized GPIb{alpha}-von Willebrand factor interaction in the mouse
- Antiplatelet Treatment After Transient Ischemic Attack and Ischemic Stroke in Patients With Cerebral Microbleeds in 2 Large Cohorts and an Updated Systematic Review
- Antithrombotic Therapy for Peripheral Artery Disease: Recent Advances
- Risk of stroke and transient ischaemic attack in patients with a diagnosis of resolved atrial fibrillation: retrospective cohort studies
- In-Hospital Outcomes of Dual Loading Antiplatelet Therapy in Patients 75 Years and Older With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention: Findings From the CCC-ACS (Improving Care for Cardiovascular Disease in China-Acute Coronary Syndrome) Project
- A protocol for an economic evaluation of a polypill in patients with established or at high risk of cardiovascular disease in a UK NHS setting: RUPEE (NHS) study
- Anti-inflammatory approaches to ischaemic stroke prevention
- TEXT messages to improve MEDication adherence and Secondary prevention (TEXTMEDS) after acute coronary syndrome: a randomised clinical trial protocol
- Impact of hepatitis C virus infection on long-term mortality after acute myocardial infarction: a nationwide population-based, propensity-matched cohort study in Taiwan
- Reduced Long-Term Risk of Aortic Aneurysm and Aortic Dissection Among Individuals With Type 2 Diabetes Mellitus: A Nationwide Observational Study
- Antithrombotic Therapy in Peripheral Artery Disease: Generating and Translating Evidence Into Practice
- When has service provision for transient ischaemic attack improved enough? A discrete event simulation economic modelling study
- Procoagulant platelets: generation, function, and therapeutic targeting in thrombosis
- Aspirin and the prevention of venous thromboembolism following total joint arthroplasty: commonly asked questions
- 2017 AHA/ACC Clinical Performance and Quality Measures for Adults With ST-Elevation and Non-ST-Elevation Myocardial Infarction: A Report of the American College of Cardiology/American Heart Association Task Force on Performance Measures
- Smoking cessation and outcome after ischemic stroke or TIA
- Antiplatelet Agents for the Treatment and Prevention of Coronary Atherothrombosis
- Contribution of whole platelet aggregometry to the endovascular management of unruptured aneurysms: an institutional experience
- Management of acute coronary syndromes: special considerations in women
- Low-Dose Aspirin Discontinuation and Risk of Cardiovascular Events: A Swedish Nationwide, Population-Based Cohort Study
- 2017 AHA/ACC Clinical Performance and Quality Measures for Adults With ST-Elevation and Non-ST-Elevation Myocardial Infarction: A Report of the American College of Cardiology/American Heart Association Task Force on Performance Measures
- Efficacy and Safety of Ticagrelor Over Time in Patients With Prior MI in PEGASUS-TIMI 54
- The role of contraindications in prescribing anticoagulants to patients with atrial fibrillation: a cross-sectional analysis of primary care data in the UK
- Aspirin Monotherapy Should Not Be Recommended for Cardioprotection in Patients With Symptomatic Peripheral Artery Disease
- Predicting major bleeding in patients with noncardioembolic stroke on antiplatelets: S2TOP-BLEED
- One-Year Incidence, Time Trends, and Predictors of Recurrent Ischemic Stroke in Sweden From 1998 to 2010: An Observational Study
- What Do Cardiology and Homeopathy Have in Common?: A Belief in Aspirin?
- A Structured Review of Antithrombotic Therapy in Peripheral Artery Disease With a Focus on Revascularization: A TASC (InterSociety Consensus for the Management of Peripheral Artery Disease) Initiative
- Thrombosis in diabetes: a shear flow effect?
- Newly Formed Reticulated Platelets Undermine Pharmacokinetically Short-Lived Antiplatelet Therapies
- Primary Prevention of Myocardial Infarction in Rheumatoid Arthritis Using Aspirin: A Case-crossover Study and a Propensity Score-matched Cohort Study
- Potent P2Y12 Inhibitors in Men Versus Women: A Collaborative Meta-Analysis of Randomized Trials
- 2016 AHA/ACC Guideline on the Management of Patients With Lower Extremity Peripheral Artery Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
- 2016 AHA/ACC Guideline on the Management of Patients With Lower Extremity Peripheral Artery Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
- 2016 AHA/ACC Guideline on the Management of Patients With Lower Extremity Peripheral Artery Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
- 2016 AHA/ACC Guideline on the Management of Patients With Lower Extremity Peripheral Artery Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
- Low-Dose Aspirin for Primary Prevention of Cardiovascular Events in Patients With Type 2 Diabetes Mellitus: 10-Year Follow-Up of a Randomized Controlled Trial
- Prevention of Stroke in Patients With Silent Cerebrovascular Disease: A Scientific Statement for Healthcare Professionals From the American Heart Association/American Stroke Association
- Aspirin Desensitization in Patients With Coronary Artery Disease: Results of the Multicenter ADAPTED Registry (Aspirin Desensitization in Patients With Coronary Artery Disease)
- Low-Dose Aspirin Is Effective Chemoprophylaxis Against Clinically Important Venous Thromboembolism Following Total Joint Arthroplasty: A Preliminary Analysis
- A Critical Appraisal of Aspirin in Secondary Prevention: Is Less More?
- Using Large-Scale Linkage Data to Evaluate the Effectiveness of a National Educational Program on Antithrombotic Prescribing and Associated Stroke Prevention in Primary Care
- Recurrent stroke risk and cerebral microbleed burden in ischemic stroke and TIA: A meta-analysis
- Contemporary evaluation and management of lower extremity peripheral artery disease
- 2016 ACC/AHA Guideline Focused Update on Duration of Dual Antiplatelet Therapy in Patients With Coronary Artery Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines: An Update of the 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention, 2011 ACCF/AHA Guideline for Coronary Artery Bypass Graft Surgery, 2012 ACC/AHA/ACP/AATS/PCNA/SCAI/STS Guideline for the Diagnosis and Management of Patients With Stable Ischemic Heart Disease, 2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction, 2014 AHA/ACC Guideline for the Management of Patients With Non-ST-Elevation Acute Coronary Syndromes, and 2014 ACC/AHA Guideline on Perioperative Cardiovascular Evaluation and Management of Patients Undergoing Noncardiac Surgery
- 2016 ACC/AHA Guideline Focused Update on Duration of Dual Antiplatelet Therapy in Patients With Coronary Artery Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
- Prescription of Guideline-Based Medical Therapies at Discharge After Carotid Artery Stenting and Endarterectomy: An NCDR Analysis
- Aspirin and Cancer
- Systematic review of aspirin for thromboprophylaxis in modern elective total hip and knee arthroplasty
- Contemporary Review on Spontaneous Coronary Artery Dissection
- Cost-Effectiveness of Percutaneous Closure of the Left Atrial Appendage in Atrial Fibrillation Based on Results From PROTECT AF Versus PREVAIL
- Clinical Update: Cardiovascular Disease in Diabetes Mellitus: Atherosclerotic Cardiovascular Disease and Heart Failure in Type 2 Diabetes Mellitus - Mechanisms, Management, and Clinical Considerations
- Ticagrelor for Prevention of Ischemic Events After Myocardial Infarction in Patients With Peripheral Artery Disease
- Personalized medicine in thrombosis: back to the future
- Aspirin for Stroke Prevention in Elderly Patients With Vascular Risk Factors: Japanese Primary Prevention Project
- Antithrombotic therapy in medically managed patients with non-ST-segment elevation acute coronary syndromes
- Atrial Fibrillation and Myocardial Infarction: A Systematic Review and Appraisal of Pathophysiologic Mechanisms
- Evolving Treatments for Acute Ischemic Stroke
- Use of Coronary Computed Tomographic Angiography to Guide Management of Patients With Coronary Disease
- Prasugrel, a Platelet P2Y12 Receptor Antagonist, Improves Abnormal Gait in a Novel Murine Model of Thrombotic Hindlimb Ischemia
- Antiplatelet regimens in the long-term secondary prevention of transient ischaemic attack and ischaemic stroke: an updated network meta-analysis
- Acute Limb Ischemia and Outcomes With Vorapaxar in Patients With Peripheral Artery Disease: Results From the Trial to Assess the Effects of Vorapaxar in Preventing Heart Attack and Stroke in Patients With Atherosclerosis-Thrombolysis in Myocardial Infarction 50 (TRA2{degrees}P-TIMI 50)
- Concomitant Use of Single Antiplatelet Therapy With Edoxaban or Warfarin in Patients With Atrial Fibrillation: Analysis From the ENGAGE AF-TIMI48 Trial
- Persistence and Discontinuation of Oral Anticoagulant: Remaining Issues Not Addressed by Phase III Clinical Trials
- Methods of a large prospective, randomised, open-label, blinded end-point study comparing morning versus evening dosing in hypertensive patients: the Treatment In Morning versus Evening (TIME) study
- Necrotic platelets provide a procoagulant surface during thrombosis
- Efficacy and Safety of Vorapaxar With and Without a Thienopyridine for Secondary Prevention in Patients With Previous Myocardial Infarction and No History of Stroke or Transient Ischemic Attack: Results from TRA 2{degrees}P-TIMI 50
- Population-Based Study of Incidence, Risk Factors, Outcome, and Prognosis of Ischemic Peripheral Arterial Events: Implications for Prevention
- Comparative effectiveness of exercise and drug interventions on mortality outcomes: metaepidemiological study
- Current management of diabetes mellitus and future directions in care
- Health and Economic Implications of National Treatment Coverage for Cardiovascular Disease in India: Cost-Effectiveness Analysis
- Oxylipid Profile of Low-Dose Aspirin Exposure: A Pharmacometabolomics Study
- Dual antiplatelet therapy with clopidogrel and aspirin after ischemic stroke: A review of the evidence
- Vorapaxar for reduction of thrombotic cardiovascular events in myocardial infarction and peripheral artery disease
- Drug-Free Platelets Can Act as Seeds for Aggregate Formation During Antiplatelet Therapy
- Long-Term Use of Cardiovascular Drugs: Challenges for Research and for Patient Care
- Coronary artery disease in the military patient
- The Multifaceted Clinical Readouts of Platelet Inhibition by Low-Dose Aspirin
- ABO Blood Group as a Model for Platelet Glycan Modification in Arterial Thrombosis
- Are at Least 12 Months of Dual Antiplatelet Therapy Needed for All Patients With Drug-Eluting Stents?: All Patients With Drug-Eluting Stents Need at Least 12 Months of Dual Antiplatelet Therapy
- Cost-effectiveness of a nurse-led internet-based vascular risk factor management programme: economic evaluation alongside a randomised controlled clinical trial
- Future Translational Applications From the Contemporary Genomics Era: A Scientific Statement From the American Heart Association
- Pharmacological Treatment and Current Management of Peripheral Artery Disease
- Trends in Myocardial Infarction Secondary Prevention: The National Health and Nutrition Examination Surveys (NHANES), 1999-2012